(Date:2/8/2010)... Feb. 8 /PRNewswire-FirstCall/ - YM BioSciences ... operational and financial results for the second quarter ... . ,, "After rigorous evaluation of numerous global ... a clinical-stage, Melbourne -based drug development company, ... David Allan , Chairman & CEO of YM ...
(Date:2/8/2010)... Feb. 8 Corgenix Medical Corporation (OTC ... diagnostic test kits, and Tulane University , today ... combat viral hemorrhagic fever (VHF), an effort that will ... for Corgenix over the life of the contract. ... a five-year contract totaling $15,224,927 to ...
(Date:2/8/2010)... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... Ph.D. to its Board of Directors effective immediately. He ... Receptos, Inc., and former Executive Chairman of Biogen Idec, ... Bill Rastetter to our Board of Directors," said ... Board of Neurocrine Biosciences. "The company is very fortunate ...
(Date:2/5/2010)... test to find undetected landmines. , Students from the ... glows green when it comes into contact with chemicals ... mixed into a colourless solution that, when sprayed on ... presence of landmines. , Researchers say that the ... from the air onto areas thought to contain landmines, ...
Breaking Biology Technology:YM BioSciences reports second quarter 2010 operational and financial results 2YM BioSciences reports second quarter 2010 operational and financial results 3YM BioSciences reports second quarter 2010 operational and financial results 4YM BioSciences reports second quarter 2010 operational and financial results 5YM BioSciences reports second quarter 2010 operational and financial results 6YM BioSciences reports second quarter 2010 operational and financial results 7YM BioSciences reports second quarter 2010 operational and financial results 8YM BioSciences reports second quarter 2010 operational and financial results 9YM BioSciences reports second quarter 2010 operational and financial results 10YM BioSciences reports second quarter 2010 operational and financial results 11YM BioSciences reports second quarter 2010 operational and financial results 12Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 2Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 3Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 4Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 5Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 6Corgenix and Tulane Announce Award of Additional NIH Contract to Expand Lassa Fever Research Towards Development of Vaccines and Improved Therapeutic Agents 7Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2... Care managers can now quickly and easily access ... environment of care (EC) compliance with the ... interviews with EC experts called "EC Bits."EC Bits audio ... feature expert advice to help keep EC managers ...
... CITY, Calif., Feb. 24 Pearl Therapeutics announced,today that ... Oxford,Finance Corporation and Silicon Valley Bank, a member ... provided the capital which will be drawn in two,tranches. ... to be working with Oxford and SVB. They ...
... Feb. 24 Novasys Medical, Inc., a ... today that Noridian,Administrative Services, LLC, a regional ... now covering the non-surgical Renessa treatment,for women ... currently,administers benefits for approximately 4 million Medicare ...
Other Biology Technology:Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2Pearl Therapeutics Secures $8 Million in Debt Financing 2Pearl Therapeutics Secures $8 Million in Debt Financing 3Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women 2... serum is collected from fasted Beagle canines of ... Available Anticoagulants: N-02: Citrate ... N-08: Potassium Oxalate N-10: ... ACD N-07: CPD N-09: ...
Collected from normal, healthy animals in carefully maintained standing herds of US orgin. Pricing: $45/unit for 1 - 10 units...
Ready-to-use; 40mg/ml X-Gal and 32mg/ml IPTG...
GOAT ANTI PPP2R5B...
Biology Products:Biology NavigationMedical Navigation